Michael Barish, Ph.D. 
Dr. Barish, Chair of the Department of Developmental & Stem Cell Biology, received his PhD from Stanford University. His team is using large-field imaging techniques to visualize tumor initiating cells in patient-derived tumor xenografts, and the spatial relationships of migrating tumor cells and the sites of proliferation and engraftment.
Wenyong Chen, Ph.D. 
Dr. Chen, Associate Professor at the Department of Cancer Biology, received his PhD from University of Alabama at Birmingham. His laboratory is interested in understanding epigenetic regulation of hematopoietic stem cell aging, leukemia development and drug resistance in leukemia stem cells.
Mark LaBarge, Ph.D. 
Dr. LaBarge, Professor at the Department of Population Sciences, received his PhD from Stanford University. His team specializes in developing human cell systems to dissect the micro-environmental and tissue-level changes in breast that arise with age for understanding why aging is a major risk factor for breast cancer.
Yilun Liu, Ph.D. 
Dr. Liu, Professor in the Department of Cancer Genetics & Epigenetics, received her PhD from Yale University. Her team focuses on uncovering the molecular etiologies of developmental abnormalities, premature aging syndromes, malignancies and chemo-resistance by the clinical mutations of the RECQ DNA helicases.
Mina Sedrak, M.D., M.S. 
Dr. Sedrak, Assistant Professor at the Department of Medical Oncology and Therapeutics Research, received his MD from Rush Medical College.  Dr. Sedrak is focused on examining barriers to clinical trial participation for older adults with cancer as a way to improve evidence based cancer therapy for this population.